Show/Hide Influenzanet map

Currently 46905 volunteers from 10 participating countries are contributing to Influenzanet:
http://www.degrotegriepmeting.nl/
Netherlands
20823 Participants
Visit partnersite
http://www.degrotegriepmeting.be/
Belgium
7247 Participants
Visit partnersite
http://preview.aktivgegengrippe.de/
Germany
82 Participants
Visit partnersite
http://preview.aktivgegengrippe.at/
Austria
10 Participants
Visit partnersite
http://preview.aktivgegengrippe.ch/
Switzerland
6 Participants
Visit partnersite
http://www.influensakoll.se/
Sweden
2654 Participants
Visit partnersite
http://flusurvey.org.uk/
United Kingdom
5522 Participants
Visit partnersite
http://www.grippenet.fr/
France
4444 Participants
Visit partnersite
http://www.gripenet.pt/
Portugal
1980 Participants
Visit partnersite
http://www.influweb.it/
Italy
4137 Participants
Visit partnersite

Influenzanet

Influenzanet is a system to monitor the activity of influenza-like-illness (ILI) with the aid of volunteers via the internet. It has been operational in The Netherlands and Belgium (since 2003), Portugal (since 2005), Italy (since 2008) and United Kingdom (since 2009), and the current objective is to implement Influenzanet in more European countries. In contrast with the traditional system of sentinel networks of mainly primary care physicians, Influenzanet obtains its data directly from the population. This creates a fast and flexible monitoring system whose uniformity allows for direct comparison of ILI rates between countries.

Any resident of a country where Influenzanet is implemented can participate by completing an online application form, which contains various medical, geographic and behavioural questions. Participants are reminded weekly to report any symptoms they have experienced since their last visit. The incidence of ILI is determined on the basis of a uniform case definition.

All results are updated daily.

Latest news

Texts prime parents to get kids a flu shot: study

Texts prime parents to get kids a flu shot: study Research in New York City suggests that sending parents educational text messages about the flu vaccine and where to get it could increase the number of kids and teens protected during flu season. Read more...


FDA approves first quadrivalent flu vaccine

FDA approves first quadrivalent flu vaccine FDA approved the first 4-strain influenza vaccine live, intranasal (FluMist Quadrivalent, MedImmune) for the prevention of influenza. Read more...


Potential flu drugs identified

Potential flu drugs identified Researchers have identified small molecules that selectively inhibit the growth of influenza A and B viruses in cell culture by targeting a component of the virus that is not exploited by currently approved anti-influenza drugs. Read more...


Epiwork